ABSTRACT: To facilitate the construction of cell-free genetic devices, we evaluated the ability of 17 different fluorescent proteins to give easily detectable fluorescence signals in real-time from in vitro transcription-translation reactions with a minimal system consisting of T7 RNA polymerase and E. coli translation machinery, i.e., the PUREsystem. The data were used to construct a ratiometric fluorescence assay to quantify the effect of genetic organization on in vitro expression levels. Synthetic operons with varied spacing and sequence composition between two genes that coded for fluorescent proteins were then assembled. The resulting data indicated which restriction sites and where the restriction sites should be placed in order to build genetic devices in a manner that does not interfere with protein expression. Other simple design rules were identified, such as the spacing and sequence composition influences of regions upstream and downstream of ribosome binding sites and the ability of non-AUG start codons to function in vitro. KEYWORDS: cell-free, fluorescent protein, transcription-translation, ribosome binding site, synthetic biology T he majority of synthetic biology research makes use of a living chassis that provides for the necessary but poorly characterized biological components required for life. Conversely, a smaller community of synthetic biologists has begun to build cell-like systems with a nonliving, cell-free chassis. 1−7 Although the cell-free branch of synthetic biology has progressed more slowly, success could provide for new technologies with several beneficial features. For example, the resulting cellular mimics would consist of fully defined components. Therefore, it should be possible to build a complete mathematical model describing the cellular mimic that could aid in designing new features. Additionally, potentially technologically problematic features of life, such as evolution, could be intentionally removed by building systems that do not replicate. A significant step forward in allowing for the construction of such well-defined, bottom-up systems came from Ueda and colleagues, who showed that coupled transcription and translation reactions can be mediated by fully defined components in vitro.
T he majority of synthetic biology research makes use of a living chassis that provides for the necessary but poorly characterized biological components required for life. Conversely, a smaller community of synthetic biologists has begun to build cell-like systems with a nonliving, cell-free chassis. 1−7 Although the cell-free branch of synthetic biology has progressed more slowly, success could provide for new technologies with several beneficial features. For example, the resulting cellular mimics would consist of fully defined components. Therefore, it should be possible to build a complete mathematical model describing the cellular mimic that could aid in designing new features. Additionally, potentially technologically problematic features of life, such as evolution, could be intentionally removed by building systems that do not replicate.
A significant step forward in allowing for the construction of such well-defined, bottom-up systems came from Ueda and colleagues, who showed that coupled transcription and translation reactions can be mediated by fully defined components in vitro. 8 Their system, hereafter referred to as the PUREsystem, consisted of T7 RNA polymerase and Escherichia coli translation machinery. Subsequent work demonstrated the compatibility of the PUREsystem with liposomes 9, 10 and with the expression of gene networks. 11 Nevertheless, there has been little attempt to better define the influences of genetic organization on protein output with purified transcription-translation machinery. Recently, a S30 E. coli cell extract translation system and the PUREsystem were used to determine the influences of different ribosome binding sites and transcriptional repressors on the synthesis of eGFP. 12, 13 Although much is known about natural, in vivo genetics, much still remains unresolved. For example, the refactoring of the T7 genome was successful in the sense that viable bacteriophage were produced; however, the refactored bacteriophage was significantly less infective.
14 Similar challenges are routinely encountered when genetic elements are inserted into organisms to engineer new circuitry. Typically, many permutations are required before desired function is achieved. 15 The situation is perhaps even more challenging for systems that exploit a cell-free chassis since biological parts are evolved to function optimally under the chemical conditions found in vivo. In vitro conditions are undoubtedly different. Further, unidentified molecular components necessary for activity in vivo may be missing from in vitro constructions. The design and implementation of predictable, genetically encoded cell-free systems is difficult because of the lack of cellfree chassis data coupled with an incomplete understanding of natural, in vivo genetics.
Here we sought to identify some practical rules for the construction of genetically encoded, cell-free systems. First, 17 different fluorescent proteins were screened for their ability to generate easily detectable fluorescence signals after in vitro transcription and translation with the PUREsystem. Fluorescent proteins then were expressed from a bicistronic construct to identify fluorescent protein pairs that could be used to quantify the influences of genetic organization on protein production. A series of synthetic operons that differed in the spacing and sequence between the two encoded genes, the spacing and sequence between the ribosome binding site and the start codon, and the influence of the first nucleotide position of the start codon on in vitro expression levels was assessed with the developed ratiometric fluorescence assay. We found that a high guanosine content inhibited translation, that sequences 5′ to the ribosome binding site were more amenable to the incorporation of restriction sites for cloning, and that ribosome binding sites were most efficient when separated from the start codon by 4−9 nucleotide positions. GUG, UUG, and CUG were functional as start codons in minimal, reconstituted translation systems, although their associated expression levels were significantly reduced.
■ RESULTS AND DISCUSSION
In Vitro Expression of Fluorescent Proteins. A total of 17 different fluorescent proteins were tested individually for their ability to give easily detectable fluorescence signals from in vitro transcription-translation reactions with the PUREsystem at 37°C. Of these 17 proteins, four (mCerulean, mCyPet, mVenus, and mYPet) contained a A206K substitution to inhibit dimerization. As seen in Figure 1a , all of the tested constructs produced easily detectable signals above background arising from the fluorescent protein except for CyPet and mCyPet. These two cyan fluorescent proteins gave slightly increased fluorescence when expressed at 30°C (Supplementary Figure  S1) . Consistent with the reported brightness of each fluorescent protein, 16 the yellow fluorescent proteins were associated with the most intense fluorescence, followed by the green, cyan, and red fluorescent proteins (Figure 1a ). Monomeric versions of Cerulean and YPet gave fluorescence intensities within 5% of their dimeric parent construct. In vitro transcribed and translated Venus was 40% more intense than mVenus; however, the error associated with the single fluorescent protein measurements was too large to make meaningful conclusions. This issue was resolved by using a ratiometric method described below. After 6 h of in vitro transcription-translation, the mVenus concentration reached 8 μM. Most of the constructs gave sigmoidal shaped kinetic profiles and were complete within 6 h. The exceptions were T-Sapphire and TagRFP-T (Supplementary Figure S2) , both of which did not reach their maximal fluorescence within 6 h. The fitting of the kinetic data to a logistic model was used to determine the time point at which the rate of fluorescence increase was maximal, which corresponded to the time required to reach half maximal fluorescence (t f/2 ) (Figure 1b,c) . Note that the t f/2 includes all of the steps involved in converting the information encoded in DNA to a fluorescence signal and does not solely describe the last oxidation step of chromophore formation. 17 The shortest t f/2 value was 79 min for GFPmut3b, and the longest t f/2 was over 300 min for TagRFP-T (Supplementary Table S4 ). The average t f/2 values for the expression of cyan, green, yellow, and red fluorescent proteins were 105, 122, 122, and 245 min, respectively. The t f/2 was 40% larger for mCerulean than Cerulean, whereas mVenus and mYPet had t f/2 values 12% and 26% smaller than Venus and YPet, respectively. On the basis of fluorescence intensity and kinetic data, Cerulean, mCerulean, super folder GFP (sfGFP), Venus, mVenus, YPet, mYPet, mRFP1, and mCherry were selected for further analysis.
To reduce experimental error, we pursued the construction of a ratiometric fluorescence system based on synthetic operons that encoded two fluorescent proteins. In this way the influences of pipetting, lamp performance, and DNA template quality and concentration, among other difficult to control variables, would be removed. To build such a ratiometric system, a red fluorescent protein was desirable because the excitation and emission spectra of red fluorescent proteins are better separated from the fluorescence spectra of other fluorescent proteins. mRFP1 and mCherry were, therefore, tested in bicistronic constructs that additionally encoded sfGFP to evaluate their utility in characterizing expression levels. More specifically, small synthetic operons containing a standard T7 transcriptional promoter, a ribosome binding site (RBS), a gene encoding sfGFP followed by a sequence that encoded the red fluorescent protein and a T7 transcriptional terminator were assembled. All of the fluorescent proteins in these constructs gave reproducible and easily detectable fluorescence signals. After 6 h of expression with purified transcription-translation machinery, the ratio of sfGFP fluorescence to mRFP1 and to mCherry fluorescence was 115.1 ± 6.9 and 49.9 ± 2.4, respectively (Supplementary Figure S3) . We chose to use mCherry for the remaining experiments, because mCherry showed more intense fluorescence from the bicistronic construct and because mCherry was shown to be more photostable than mRFP1. 16 We next assembled six additional synthetic operons that encoded different fluorescent proteins followed by a sequence coding for mCherry. After in vitro transcription and translation, the fluorescence profiles were similar to those obtained with the single fluorescent protein constructs in that the yellow fluorescent proteins were the most intense, followed by green, and cyan fluorescent proteins (Figure 1d ). However, the error of each ratiometric measurement was significantly reduced (relative standard error <8%) in comparison to the data obtained from the monocistronic, single fluorescent protein constructs (relative standard error <60%, excluding TagRFP-T). The A206K substitution that inhibits protein dimerization had a small effect on fluorescence intensity. More specifically, the ratiometric response, i.e., the fluorescence intensity of the fluorescent protein tested divided by the fluorescence intensity of mCherry, for mVenus, mYPet, and mCerulean were within 10% of the values measured for Venus, YPet, and Cerulean, respectively. The ratiometric response over time showed that stable readings could be taken after 3 h for all constructs tested (Supplementary Figure S4) .
It was not clear from the outset which fluorescent proteins would perform well in vitro with minimal transcriptiontranslation machinery. Although the physical characteristics of individually purified proteins, such as brightness and photostability, are useful in deciding if a protein could be suitable for a specific application, these parameters are not enough to understand if in vitro expression will give a robust, reproducible signal. For example, if in vitro produced protein is insoluble, folds slowly, or requires a long period of time for chromophore formation, then that protein would be less useful as an in vitro genetic reporter. Even within cells, differences in fluorescent protein behavior have been noted, particularly for multidomain proteins. 18 Despite these difficulties, we found that most of the fluorescent proteins tested function satisfactorily in in vitro transcription-translation reactions with the PUREsystem at 37°C
. One exception is CyPet, which fails to give a significant fluorescent output. The fact that CyPet expression at 30°C gives a better fluorescence signal is consistent with previous reports on the poor folding properties of CyPet. 16 If a fluorescent protein with cyan spectral properties were desired, cerulean would be a better choice. The green fluorescent proteins are generally bright and rapidly give rise to fluorescence signals, e.g., the t f/2 of sfGFP is 92 min. sfGFP is particularly amenable to in vitro transcription-translation; however, GFPmut3b performs similarly well. GFPmut3b is one of the more common fluorescent proteins used in synthetic biology. Two of the tested green fluorescent proteins fluoresce upon excitation with near-UV light. Of these two, T-Sapphire has a t f/2 approximately 100 min longer than that of GFPuv. Therefore, GFPuv would be better for real-time detection assays than T-Sapphire. The yellow fluorescent proteins Venus and YPet are the brightest fluorescent proteins that we tested and have t f/2 values below 150 min. Venus and YPet are excellent choices to monitor in vitro reactions particularly when low protein output is expected, e.g., when expressing inside of vesicles. 19 YPet is more photostable, 16 which could be important depending upon the nature of the planned experiments. The red fluorescent proteins mCherry and mRFP1 perform similarly well in in vitro transcriptiontranslation reactions, but mCherry is more photostable. Although TagRFP-T is a highly photostable red fluorescent protein alternative, the long t f/2 of TagRFP-T limits its usefulness.
All of the seven tested double fluorescent protein constructs performed well, and so the choice of fluorescent protein pairs depends on the specifics of the experimental setup. We found that the mVenus-mCherry pair gives easy to detect fluorescence signals and reproducible data without interference between the emission of mVenus and the emission of mCherry. Therefore, the subsequent experiments that probed the effects of genetic organization on protein production were performed with synthetic operons encoding mVenus and mCherry. However, for the remaining experiments the order of the genes was reversed so that mCherry was encoded first followed by mVenus in the bicistronic message. In this way, the lower intensity fluorescent protein, i.e., mCherry, could be used to provide the reference fluorescence signal and the influences of the region between the two genes on the expression of the brighter fluorescent protein, i.e., mVenus, could be more easily assessed. Nevertheless, care should be taken in interpreting the resulting data. The assay can be used to characterize how changes in DNA sequence influence the ratio of the two encoded proteins. However, the assay does not differentiate between the decrease of expression of gene 1 or the increase of expression of gene 2. In other words, multiple mechanisms can give indistinguishable results.
Influence Figure  2 ). Although differences in expression levels were observed, the differences did not correlate with the length of the spacer. For example, the 5 bp and the 31 bp spacer containing constructs both resulted in higher relative expression of gene 2 when compared with the 20 bp spacer. This suggested that the variance in fluorescence ratios resulted from something other than spacer length, such as sequence composition. For the remainder of the experiments, the 31 bp spacer construct (RL027A) was used as the reference.
Since the length of the spacer between gene 1 and RBS 2 did not appear to be correlated with the expression of gene 2, we wondered if the sequence composition rather than the length was responsible for the observed differences in expression. We decided to investigate the influences of sequence composition by incorporating different restriction sites immediately upstream to RBS 2. In this way we hoped to additionally identify restriction sites useful for the assembly of genetically encoded devices. Therefore, in each of the tested constructs, the 31 bp spacer length was maintained, and sequences containing a NdeI, BamHI, NheI, EcoRI, NotI, or a scar site were incorporated. The scar site represented the sequence that results from standard BioBrick assembly in which complementary XbaI and SpeI digested products are ligated. 20 Additionally, the U before the AAGGAG RBS was mutated to a G, since a U residue is capable of base-pairing with 16S rRNA. A significant effect of sequence composition on the amount of protein produced was observed (Figure 3) . The introduction of a NotI site was the most inhibitory, bringing relative expression down by 70% in comparison to the reference RL027A construct. Of the restriction sites tested, NdeI and EcoRI restriction site sequences were the most conducive to high expression (84% and 77% relative expression, respectively). Removing the additional base-pair of the RBS, i.e., the U to G mutation, decreased protein production by 44%, consistent with the observed decrease in expression from the 20 bp spacer construct described above that contained the same nucleotide at this position.
Influence of Sequences Downstream of the Ribosome Binding Site. Having probed the influences of the region 5′ to RBS 2, we next investigated the impact of the region 3′ to RBS 2. First, we altered the spacing between RBS 2 and the start codon of gene 2 one nucleotide at a time from −2 to 15 bp. Here the spacing nomenclature followed the aligned spacing described by Chen et al. 21 in which the RBS was aligned with Figure S5) . The results were consistent with previous in vivo studies, 22 which showed a Gaussian distribution of activity with optimal aligned spacing between 4 and 9 bp (Figure 4 ). Spacer lengths shorter or longer than this range generally resulted in dramatically decreased protein production. For example, the 3 bp spacer produced 72% less protein than the 4 bp spacer. Similarly, the 10 bp spacer reduced protein synthesis by 60% when compared to the 9 bp spacer construct. For the specific constructs tested in this study, the 6 bp spacer produced the most protein. Since protein expression was detected with the shortest spacer tested on both sides of RBS 2, we also made a minimal construct with a 0 bp spacer between the UAA stop codon of gene 1 and RBS 2 and −2 aligned spacing between RBS 2 and the start codon of gene 2. The synthesis of mVenus from this minimally spaced construct was low but still detectable (3% relative to RL027A).
Next, we evaluated the effect of sequence composition of the region between RBS 2 and the AUG start codon of gene 2 on expression levels. This region of the reference sequence RL027A was designed to be high in A-U content and low in G content because a sequence that is known to facilitate gene expression, i.e., the T7 phage gene 10 leader sequence, 23 has similar characteristics. Sequences that contained the same restriction sites tested above for the region upstream of RBS 2 were placed immediately upstream of the start codon of gene 2. An additional BioBrick scar site also was screened that was shorter and thus thought to interfere less with translation. The presence of an A three nucleotides upstream of the start codon was evaluated since an A at this position is frequently found in prokaryotic and eukaryotic sequences. 24, 25 A C-rich sequence was evaluated since a previous in vitro study 26 found increased expression associated with high C-content. Finally, mutations that introduced additional base-pairing with the 16S rRNA were added. The data showed a strong influence of sequence composition on protein yields with the NotI restriction site being the most inhibitory, decreasing expression by 87% ( Figure 5 ). The NdeI restriction site was the most conducive to protein synthesis (76% relative expression). Both scar sequences resulting from BioBrick assembly performed similarly, decreasing translation by over 50%. The C-rich sequence greatly decreased protein expression by 98% relative to RL027A. Neither an A residue three nucleotides preceding the start codon nor the expansion of the RBS-anti-RBS basepairing region increased protein production in the tested constructs.
Finally, we investigated whether other codons could substitute for the AUG start codon. In E. coli, GUG and UUG function as start codons at a frequency of 14% and 3%, respectively. 25 If non-AUG codons can function as start codons in minimally reconstituted systems, then these alternate start codons could be used to control protein levels. Also, knowledge regarding the functionality of non-AUG start codons could help to identify internal RBS-start codon pairs that could potentially interfere with the intended activity of genetic devices. We therefore substituted a GUG, UUG, and CUG in place of the AUG start codon and measured the production of mVenus. All of the alternate start codons produced protein, albeit at a significantly reduced level between 12% and 27% relative to the AUG start codon containing reference construct ( Figure 6) .
Considerations for the Assembly of in Vitro Genetic Systems. To determine if simple rules could be formulated that would facilitate the construction of genetically encoded, cell-free devices, the collected data were statistically analyzed. First, we sought to determine which regions were more amenable to the incorporation of restriction sites. A paired t test showed that sequences upstream of RBS 2 had less influence on the protein fluorescence ratios than the sequence between RBS 2 and the start codon (p-value = 0.0145). Next, sequences immediately 5′ and 3′ to RBS 2 (8 bp each) were considered. The resulting data from 22 synthetic operons were fit to multiple regression models that searched for first and second order interactions between base composition that correlated with the measured fluorescence intensity ratios. The resulting model was statistically significant (F-test p-value = 8.79 × 10 −7 ) and described almost 75% of the data variability (adjusted r 2 = 0.7453). The estimated parameters (Supplementary Table S1 ) revealed a strong effect of the G content in sequence composition of the region 5′ to RBS 2 (p-value <0.001). More specifically, a high G content negatively correlated with the fluorescence ratio, whereas combined A-U-rich sequences in the region 3′ to RBS 2 positively correlated with the fluorescence intensity ratio (p-value <0.001).
Taken together, the data indicate that the nucleotide sequence between genes 1 and 2 influence protein production, but not uniformly. The spacing upstream of the RBS is not as strong of a determinant of expression levels as the spacing downstream of the RBS. The one construct that deviates from this trend (RL024A) contains a mutation that decreases the number of potential base-pairs between the mRNA and the 16S rRNA. Most of the constructs tested here contain six to seven potential base-pairing interactions between the Shine-Dalgarno (RBS) and the anti-Shine-Dalgarno site of the ribosome. The introduction of additional base-pairing does not facilitate expression, consistent with previous studies that show that on average E. coli mRNA RBS sequences interact with the ribosome via six base-pairs and that the strengthening of the interaction often decreases rather than increases protein synthesis. 27 The optimal aligned spacing between the RBS and the start codon and the functionality of alternate start codons is the same for in vitro protein production with the PUREsystem and for natural E. coli expression.
Taken together, a few simple rules for the construction of in vitro genetic systems can be formulated from the acquired data. Restriction sites should either be placed before the RBS, since this region is more amenable to sequence modification, or a NdeI site that overlaps with the start codon should be exploited. If high protein levels are desired, then the aligned RBS spacing should be between four and nine nucleotides and the spacer sequence should be high in A and T content and low in G content. The use of alternate start codons can be used to . Alternate start codons. The ability of UUG, GUG, and CUG to function as start codons in vitro was evaluated. Relative intensities are averages of three replicates and plotted in reference to the AUG start codon containing construct. Each bicistrionic construct was expressed in vitro with the PUREsystem at 37°C for 6 h. Gene 1 encoded mCherry, and gene 2 encoded mVenus. The AUG, UUG, GUG, and CUG start codon constructs were RL027A, LM019A, LM018A, and LM020A, respectively. significantly reduce protein synthesis, when needed, and the spacing between the end of one gene and the RBS of the next gene is not crucial. Nevertheless, the complexity of transcription and translation ensures that there are many more factors that influence gene expression than was probed here. mRNA can interact with regions of the ribosome other than the 3′-terminus of the 16S rRNA 26−29 and the folding of mRNA significantly affects protein synthesis. 19,30−33 Further studies with purified, in vitro systems likely will aid in better understanding these processes and in facilitating the synthesis of more complex cellular mimics.
■ METHODS Genetic Constructs. Genes encoding the fluorescent proteins were synthesized by Genscript or Mr. Gene, except for super folder GFP (BBa_I746916), GFPmut3b (BBa_E0040), and mRFP1 (BBa_E1010), which were from the registry of standard biological parts (http://partsregistry. org), and eGFP, which was from Roche. Mutagenesis was either performed by Genscript or through the use of phusion sitedirected mutagenesis (Finnzymes). All genes were subcloned into pET21b by restriction digestion and ligation with NdeI and BamHI, except for super folder GFP and GFPmut3b, which used NheI and BamHI sites. All constructs were confirmed by sequencing at Genechron or Eurofins MWG Operon. The DNA sequences of all the constructs used are provided in the Supporting Information (Table S2) .
Transcription-Translation Reactions. Plasmids were amplified in E. coli DH5α or NovaBlue and purified with Wizard Plus SV Minipreps DNA Purification System (Promega) or QIAprep Spin Miniprep Kit (Qiagen). Subsequently, the DNA was phenol-chloroform extracted, ethanol precipitated, and resuspended in deionized and diethylpyrocarbonate (DEPC) treated water. A 250 ng portion (2 nM final concentration) of DNA was used for each transcription-translation reaction with the PURExpress in vitro protein synthesis kit (New England BioLabs) supplemented with 20 units of human placenta RNase inhibitor (New England BioLabs). The final volume of each reaction was 25.5 μL. Reactions were monitored by fluorescence spectroscopy with a Photon Technology International (PTI) QuantaMaster 40 UV−vis spectrofluorometer equipped with two detectors (T-format). Excitation and emission wavelengths were specific for each fluorescent protein (Supplementary Table S3 ). The reaction components, except for the DNA template, were assembled on ice and then incubated at 37°C in the spectrofluorometer. Subsequently, the reaction was initiated by the addition of DNA template. Mineral oil was layered on top of each sample to inhibit evaporation during the course of the experiment. Control experiments with GFPmut3b showed that mineral oil did not influence the appearance of fluorescence. Each reaction was repeated at least three times. An Agilent 8453 UV−vis spectrophotometer was used to quantify mVenus protein concentration by using an extinction coefficient at 515 nm of 92,200 M −1 s −1 .
16
Data analysis. All statistical analyses used R statistical computing software. 34 The single protein construct fluorescent data were fit to 
where K, B, and t f/2 were the upper asymptote, growth rate, and time of maximum growth, respectively (Supplementary Table  S4 ). The parameters were estimated by using a nonlinear leastsquares analysis with the Gauss−Newton algorithm. The mean values and standard errors were then calculated from data from three replications. The influence of spacer nucleotide composition on the fluorescence intensity was determined with multiple regression models. The models were estimated and reduced by using stepwise regression with a penalty term that was selected by minimum predictive mean squared error based on repeated cross-validation (10% leave-out). The best predictive models were obtained by using a stringent criterion (twice the Bayesian Information Criterion, BIC). We then estimated the model with such a penalty term on the whole set of operon spacer data. Paired t tests were used to test whether the restriction sites 5′ or 3′ to RBS 2 affected differently fluorescence intensity ratios.
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